Indymedia e' un collettivo di organizzazioni, centri sociali, radio, media, giornalisti, videomaker che offre una copertura degli eventi italiani indipendente dall'informazione istituzionale e commerciale e dalle organizzazioni politiche.
toolbar di navigazione
toolbar di navigazione home | chi siamo · contatti · aiuto · partecipa | pubblica | agenda · forum · newswire · archivi | cerca · traduzioni · xml | classic toolbar di navigazione old style toolbarr di navigazione old style toolbarr di navigazione Versione solo testo toolbar di navigazione
Campagne

CD GE2001 - un'idea di Supporto Legale per raccogliere fondi sufficienti a finanziare la Segreteria Legale del Genoa Legal Forum


IMC Italia
Ultime features in categoria
[biowar] La sindrome di Quirra
[sardegna] Ripensare Indymedia
[lombardia] AgainstTheirPeace
[lombardia] ((( i )))
[lombardia] Sentenza 11 Marzo
[calabria] Processo al Sud Ribelle
[guerreglobali] Raid israeliani su Gaza
[guerreglobali] Barricate e morte a Oaxaca
[roma] Superwalter
[napoli] repressione a Benevento
[piemunt] Rbo cambia sede
[economie] il sangue di roma
Archivio completo delle feature »
toolbarr di navigazione
IMC Locali
Abruzzo
Bologna
Calabria
Genova
Lombardia
Napoli
Nordest
Puglia
Roma
Sardegna
Sicilia
Piemonte
Toscana
Umbria
toolbar di navigazione
Categorie
Antifa
Antimafie
Antipro
Culture
Carcere
Dicono di noi
Diritti digitali
Ecologie
Economie/Lavoro
Guerre globali
Mediascape
Migranti/Cittadinanza
Repressione/Controllo
Saperi/Filosofie
Sex & Gender
Psiche
toolbar di navigazione
Dossier
Sicurezza e privacy in rete
Euskadi: le liberta' negate
Antenna Sicilia: di chi e' l'informazione
Diritti Umani in Pakistan
CPT - Storie di un lager
Antifa - destra romana
Scarceranda
Tecniche di disinformazione
Palestina
Argentina
Karachaganak
La sindrome di Quirra
toolbar di navigazione
Autoproduzioni

Video
Radio
Print
Strumenti

Network

www.indymedia.org

Projects
oceania
print
radio
satellite tv
video

Africa
ambazonia
canarias
estrecho / madiaq
nigeria
south africa

Canada
alberta
hamilton
maritimes
montreal
ontario
ottawa
quebec
thunder bay
vancouver
victoria
windsor
winnipeg

East Asia
japan
manila
qc

Europe
andorra
antwerp
athens
austria
barcelona
belgium
belgrade
bristol
croatia
cyprus
estrecho / madiaq
euskal herria
galiza
germany
hungary
ireland
istanbul
italy
la plana
liege
lille
madrid
nantes
netherlands
nice
norway
oost-vlaanderen
paris
poland
portugal
prague
russia
sweden
switzerland
thessaloniki
united kingdom
west vlaanderen

Latin America
argentina
bolivia
brasil
chiapas
chile
colombia
ecuador
mexico
peru
puerto rico
qollasuyu
rosario
sonora
tijuana
uruguay

Oceania
adelaide
aotearoa
brisbane
jakarta
manila
melbourne
perth
qc
sydney

South Asia
india
mumbai

United States
arizona
arkansas
atlanta
austin
baltimore
boston
buffalo
charlottesville
chicago
cleveland
colorado
danbury, ct
dc
hawaii
houston
idaho
ithaca
la
madison
maine
michigan
milwaukee
minneapolis/st. paul
new hampshire
new jersey
new mexico
new orleans
north carolina
north texas
ny capital
nyc
oklahoma
philadelphia
pittsburgh
portland
richmond
rochester
rogue valley
san diego
san francisco
san francisco bay area
santa cruz, ca
seattle
st louis
tallahassee-red hills
tennessee
urbana-champaign
utah
vermont
western mass

West Asia
beirut
israel
palestine

Process
discussion
fbi/legal updates
indymedia faq
mailing lists
process & imc docs
tech
volunteer
Vietnam last on flu vaccine list (2004)
by Debora MacKenzie Monday, Sep. 19, 2005 at 4:08 PM mail:

Vietnam last on flu vaccine list

* 19:00 21 January 2004
* Exclusive from New Scientist Print Edition
* Debora MacKenzie


Drug company contracts and intellectual property rights are impeding efforts to ensure an outbreak of bird flu in Vietnam does not result in a deadly human pandemic.

All the victims so far got the disease from poultry, but the big fear is that the virus could turn into a form capable of spreading from person to person. A flu vaccine that might help prevent this will soon become available, but instead of going to Vietnam it will be sent to rich countries to fulfil existing contracts.

And researchers who have created vaccines that might save us if the bird flu does start spreading between people are unsure how to proceed without falling foul of patent rights.

Doctors have been warning for years that another flu pandemic as deadly as the 1918 one is inevitable, and many worry it could be about to happen. After an outbreak of the H5N1 strain of bird flu in poultry, Vietnam has reported 18 suspected human cases, 15 of whom have died. The World Health Organization has so far confirmed that five of the cases were caused by the H5N1 strain. Unlike previous H5N1 outbreaks, the victims are mostly children.

So far there is no sign of the bird virus spreading between people. But if someone is infected by H5N1 and a normal human flu virus at the same time, the viruses could recombine.

This might give rise to a new virus able to spread among people as easily as human flu but far more deadly, partly because it would bear the bird flu's H5 and N1 surface proteins, which human immune systems have not been primed to recognise.


Fujian strain

To prevent this, the WHO wants to give the normal flu vaccine to everyone who might come into contact with sick poultry, as has been done in past outbreaks of bird flu. The Belgian-based company Solvay, a major flu vaccine producer, is supplying the WHO with the vaccine used in the northern hemisphere this winter. But research published last week by the US Centers for Disease Control shows that this vaccine will not prevent most infections, because it is not effective against the Fujian strain now circulating.

The vaccine for the next southern hemisphere winter, which will be available in February, will protect against Fujian. But Solvay and GlaxoSmithKline have both told New Scientist that they must first supply the vaccine to contracted customers in countries like Australia, and are unlikely to have any left for Vietnam.

If the H5N1 does start spreading between humans, a specific vaccine against it will be needed. Two labs, the National Institute for Biological Standards and Control (NIBSC) in the UK and St Jude Children's Research Hospital in Memphis, Tennessee, have each made an H5N1 vaccine virus in cell cultures which could be used to mass produce a vaccine. Neither have been tested yet against the specific H5N1 strain found in Vietnam but both protect animals against similar strains.

Standard production methods do not work for H5N1 vaccines, partly because the virus kills the chick embryos normally used to grow flu vaccine. Instead, the labs used a technique called "reverse engineering", which involves using genetic sequences called plasmids.


Patent issues

The reverse engineering patent, however, is held by the biotech company Medimmune of Gaithersburg, Maryland, and the plasmids used are patented by various companies, all of whom will be entitled to payment if their property is used to make a commercial product.

Wood says he does not know how the experimental vaccine can possibly be put into production quickly when there are complicated patent issues involved. "You can't sort these things out when there's a pandemic sweeping the world."

"If people felt we were facing a pandemic situation, we would waive intellectual property rights," says Jamie Lacey of Medimmune, but it is not clear whether the other patent holders would do the same.

Of course, if a serious pandemic took hold, worries about patents would be swept aside. But delays in vaccine production caused by the initial uncertainty could cost many lives. Wood says there should be a clearly defined "trigger" point at which health authorities will be allowed to press ahead with plans for producing a vaccine without fear of violating patent laws.

versione stampabile | invia ad un amico | aggiungi un commento | apri un dibattito sul forum
©opyright :: Independent Media Center
Tutti i materiali presenti sul sito sono distribuiti sotto Creative Commons Attribution-ShareAlike 2.0.
All content is under Creative Commons Attribution-ShareAlike 2.0 .
.: Disclaimer :.

Questo sito gira su SF-Active 0.9